HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 1,453-1,464 of 7,264
Drug study icon
CompletedNCT02422186

Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression

What is this study about?

This study evaluated the safety and effectiveness of Esketamine for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including San Diego
DepressionMedication studyAges 65+
Countries
United States, France, United Kingdom, + 9 others
Sponsor
Janssen Research & Development, LLC
Device study icon
UnknownNCT06323486

Accelerated Bilateral Sequential Theta Burst Stimulation in Older Adults With Treatment-resistant Depression

Official study title

Effects of Accelerated Bilateral Sequential Theta Burst Stimulation on Dual-task Cost, Depression, Cognition and Other Outcomes in Older Adults With Treatment-resistant Depression: A Randomized, Double-blind, Sham-controlled Trial

Current recruitment status is unconfirmed.

In Toronto
DepressionDevice studyAges 50+
Countries
Canada
Sponsor
Ontario Shores Centre for Mental Health Sciences
Other study type icon
CompletedNCT07099235

Chart Review of Patients Undergoing Ketamine Treatments for Depression

Official study title

Retrospective Chart Review of Patients Undergoing Intravenous Ketamine Treatments for Treatment-resistant Depression

This study has finished and is no longer accepting participants.

In Mississauga
DepressionObservational studyAges 18+
Countries
Canada
Sponsor
Sunnybrook Health Sciences Centre
Device study icon
CompletedNCT01983904

DBS for Treatment Resistant Depression

Official study title

Therapeutic Brain Stimulation for Refractory Depression

This study has finished and is no longer accepting participants.

In Calgary
DepressionDevice studyAges 20–70
Countries
Canada
Sponsor
University of Calgary
Device study icon
Active Not RecruitingNCT01798407

DBS of the Lateral Habenula in Treatment-Resistant Depression

Official study title

A Clinical Pilot Study Examining Bilateral Inhibition of the Lateral Habenula as a Target for Deep Brain Stimulation in Intractable Depression

This study is no longer accepting new participants.

In Houston
DepressionDevice studyAges 21–70
Countries
United States
Sponsor
Wayne Goodman MD
Device study icon
Enrolling By InvitationNCT07569133

Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in people with Parkinson's Disease

Official study title

Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease : A Single-Center, Randomized, Double-Blinded, Sham-Controlled, Parallel-Design, Investigator-Initiated Exploratory Clinical Trial

This study is by invitation only.

In Daegu
DepressionDevice studyAges 40–90
Countries
South Korea
Sponsor
Ho-Won Lee
Device study icon
CompletedNCT05194267

Intensive tDCS for MDD: Feasibility Study

Official study title

Intensive Transcranial Direct Current Stimulation in the Treatment of Major Depression: Feasibility Study

This study has finished and is no longer accepting participants.

In Montreal
DepressionDevice studyAges 18–65
Countries
Canada
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.